BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 10917215)

  • 1. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.
    Toikka P; Irjala K; Juvén T; Virkki R; Mertsola J; Leinonen M; Ruuskanen O
    Pediatr Infect Dis J; 2000 Jul; 19(7):598-602. PubMed ID: 10917215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin in children admitted to hospital with community acquired pneumonia.
    Moulin F; Raymond J; Lorrot M; Marc E; Coste J; Iniguez JL; Kalifa G; Bohuon C; Gendrel D
    Arch Dis Child; 2001 Apr; 84(4):332-6. PubMed ID: 11259234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
    Nascimento-Carvalho CM; Cardoso MR; Barral A; Araújo-Neto CA; Guerin S; Saukkoriipi A; Paldanius M; Vainionpää R; Lebon P; Leinonen M; Ruuskanen O; Gendrel D
    Scand J Infect Dis; 2010 Sep; 42(9):644-9. PubMed ID: 20438288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.
    Gendrel D; Raymond J; Coste J; Moulin F; Lorrot M; Guérin S; Ravilly S; Lefèvre H; Royer C; Lacombe C; Palmer P; Bohuon C
    Pediatr Infect Dis J; 1999 Oct; 18(10):875-81. PubMed ID: 10530583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination?
    Korppi M
    Pediatr Int; 2004 Oct; 46(5):545-50. PubMed ID: 15491381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
    Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
    Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
    BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
    Kang YA; Kwon SY; Yoon HI; Lee JH; Lee CT
    Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings.
    Korppi M; Remes S; Heiskanen-Kosma T
    Pediatr Pulmonol; 2003 Jan; 35(1):56-61. PubMed ID: 12461740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
    Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
    Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
    Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
    J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Values of combined C-reactive protein, procalcitonin and serum amyloid A in differential diagnosis of bacterial and non-bacterial community acquired pneumonia in children.
    Su W; Ju L; Hua Q; Hu J; Qian W
    Diagn Microbiol Infect Dis; 2023 Feb; 105(2):115865. PubMed ID: 36521211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
    Agnello L; Bellia C; Di Gangi M; Lo Sasso B; Calvaruso L; Bivona G; Scazzone C; Dones P; Ciaccio M
    Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
    Bafadhel M; Clark TW; Reid C; Medina MJ; Batham S; Barer MR; Nicholson KG; Brightling CE
    Chest; 2011 Jun; 139(6):1410-1418. PubMed ID: 21030489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory response in mixed viral-bacterial community-acquired pneumonia.
    Bello S; Mincholé E; Fandos S; Lasierra AB; Ruiz MA; Simon AL; Panadero C; Lapresta C; Menendez R; Torres A
    BMC Pulm Med; 2014 Jul; 14():123. PubMed ID: 25073709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
    Galetto-Lacour A; Alcoba G; Posfay-Barbe KM; Cevey-Macherel M; Gehri M; Ochs MM; Brookes RH; Siegrist CA; Gervaix A
    Pediatr Infect Dis J; 2013 Nov; 32(11):1175-9. PubMed ID: 23694836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.
    España PP; Capelastegui A; Bilbao A; Diez R; Izquierdo F; Lopez de Goicoetxea MJ; Gamazo J; Medel F; Salgado J; Gorostiaga I; Quintana JM;
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3397-405. PubMed ID: 23010902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin and C-reactive protein as predictors of blood culture positivity among hospitalised children with severe pneumonia in Mozambique.
    Díez-Padrisa N; Bassat Q; Morais L; O'Callaghan-Gordo C; Machevo S; Nhampossa T; Ibarz-Pavón AB; Quintó L; Alonso PL; Roca A
    Trop Med Int Health; 2012 Sep; 17(9):1100-7. PubMed ID: 22809300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.